Arrowstreet Capital, Limited Partnership Tandem Diabetes Care Inc Transaction History

Arrowstreet Capital, Limited Partnership

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$53.22 - $123.09 $5.45 Million - $12.6 Million	102,408 Added 1079.0%	111,899 $6.62 Million
Q1 2022 May 13, 2022	BUY	$101.89 - $150.09 $967,037 - $1.42 Million	9,491 New	9,491 $1.1 Million
Q2 2021 Aug 13, 2021	SELL	$77.0 - $100.19 $7.56 Million - $9.83 Million	-98,162 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$81.28 - $104.34 $1.38 Million - $1.77 Million	-16,922 Reduced 14.7%	98,162 $8.66 Million
Q4 2020 Feb 12, 2021	BUY	$86.4 - $121.75 $9.94 Million - $14 Million	115,084 New	115,084 $11 Million
Q1 2020 May 15, 2020	SELL	$47.37 - $90.04 $4.38 Million - $8.33 Million	-92,500 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$53.13 - $71.19 $4.91 Million - $6.59 Million	92,500 New	92,500 $5.51 Million

354

71.9M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.28B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.